New Research Confirms Cardihab participants lived longer, healthier lives
New Research Confirms Cardihab participants lived longer, healthier lives and with better value healthcare vs usual care
Cardihab’s digitally enabled cardiac rehabilitation (DeCR) program has been shown to cost effectively improve survival and quality of life, for patients with coronary heart disease, according to a new health economics analysis published in the European Journal of Preventive Cardiology (EJPC).
The independent evaluation was conducted by The Baker Institute, and analysed data from Medibank participants that accessed Cardihab’s digital therapeutic for cardiac rehabilitation. This study adds to the growing body of evidence that digital models of care can deliver not only clinically meaningful outcomes, but also economic value to health systems. Furthermore, the lead author of the publication Justin Braver, won a prestigious award at European Society of Cardiology in Madrid for Young Investigator Award for this research.
Key Findings from the EJPC Publication1
- Cardihab improved survival
- +1.434 quality-adjusted life years (QALYs) gained compared with usual care - comparable to leading cardiovascular medicines and interventions
- Simulation showed up to +6 additional years of quality-adjusted life
- More cost-effective than usual care in 87% of simulations
These findings reinforce the program’s potential to support patients in achieving longer and healthier lives, while also representing better value for health services and funders.
Cardiac Rehab is one of the few post MI/post procedure strategies that tackles multiple risk factors at once (exercise, diet, medication adherence, mental health), so its health gains are broad, rather than targeting a single disease mechanism.
“This study reinforces the potential for validated digital therapeutics to deliver meaningful and real health outcomes and economic value for patients, clinicians, and the health system.” - Helen Souris Cardihab CEO
Complementary Outcomes Evidence
This study follows the recent European Heart Journal publication evaluating Medibank’s Heart Health at Home program, delivered by Amplar Health using Cardihab’s platform, which demonstrated results including:
- 71% reduction in hospital readmission bed days within 3 months2
- 91% completion rates, significantly higher than global benchmarks2
- Improvements in quality of life, mental health, and self-management2
Together, these studies provide world-class evidence that Cardihab’s digital therapeutic platform can deliver clinically effective outcomes, while reducing the economic burden associated with coronary heart disease.
Opportunities for Health Services and Funders
As we continue to see significant gaps in access to cardiac rehabilitation across Australia whereby 80% miss out, preventable readmissions, persistent bed day challenges, the findings of these studies highlight the role Cardihab can play in solving these problems:
- Supporting health services to improve care reach, quality and impact.
- Providing patients with validated, personalised, accessible options for rehabilitation
- Delivering scalable, cost-effective care, to more people than conventional models.
To join this movement and become one of the expanding network of Cardihab providers contact us.
1.Braver, J., Marwick, T.H., Salim, A., et al. (2025). Cost-effectiveness of a digitally enabled cardiac rehabilitation programme for patients with coronary heart disease. European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwaf512
2.Braver, J., Marwick, T.H., Hakamuwalekamlage, D., et al. (2025). Effects of a digitally enabled cardiac rehabilitation intervention on risk factors, recurrent hospitalization and mortality. European Heart Journal – Digital Health, ztaf043. https://doi.org/10.1093/ehjdh/ztaf043